CryoPort Inc (CYRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges [Yahoo! Finance]
CryoPort, Inc. (CYRX)
NASDAQ:AMEX Investor Relations:
ir.cryoport.com
Company Research
Source: Yahoo! Finance
Positive Points CryoPort Inc ( NASDAQ:CYRX ) achieved total annual revenues of $228.4 million in 2024, aligning with expectations. The life sciences service business experienced double-digit year-over-year growth, with bio storage and bioservices showing significant expansion. Revenue from commercial cell and gene therapies increased by 37% in Q4 and 20% for the full year. CryoPort Inc ( NASDAQ:CYRX ) supported a record number of 701 clinical trials, indicating potential commercial revenue opportunities. The company improved its gross margin to 45.8% in Q4 2024, up from 40.6% in the same period last year. Negative Points 2024 was a challenging year for the life sciences sector due to macroeconomic conditions and market dynamics. The cryogenic systems market experienced a downturn, impacting the company's product segment. There is uncertainty regarding the impact of tariffs on aluminum and stainless steel, which could affect costs. The company has not provided spec
Show less
Read more
Impact Snapshot
Event Time:
CYRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYRX alerts
High impacting CryoPort, Inc. news events
Weekly update
A roundup of the hottest topics
CYRX
News
- How Recent Developments Are Rewriting the Story for Cryoport and Its Valuation Outlook [Yahoo! Finance]Yahoo! Finance
- Cryoport: Picks And Shovels For The Gene Therapy Boom [Seeking Alpha]Seeking Alpha
- CryoPort (NASDAQ:CYRX) had its "sell (d)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- How the Story Behind Cryoport Is Evolving After Recent Analyst and Market Developments [Yahoo! Finance]Yahoo! Finance
- CryoPort (NASDAQ:CYRX) had its "buy" rating reaffirmed by analysts at UBS Group AG.MarketBeat
CYRX
Earnings
- 11/4/25 - Beat
CYRX
Sec Filings
- 12/12/25 - Form 4
- 12/10/25 - Form 144
- 11/12/25 - Form SCHEDULE
- CYRX's page on the SEC website